China Biologic Products Holdings Inc - Company Profile
Powered by
All the data and insights you need on China Biologic Products Holdings Inc in one report.
- Save hours of research time and resources with
our up-to-date China Biologic Products Holdings Inc Strategy Report
- Understand China Biologic Products Holdings Inc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
China Biologic Products Holdings Inc (China Biologic) is a biopharmaceutical company that focuses on research and development, production, commercialization of plasma-based products. The company’s products find application in medical emergencies and for the treatment and prevention of life threating and immune-deficiency related diseases. The company is also involved in the sales of medical devices, mainly regenerative medical biomaterial products. Few of the products of company include are Human Albumin, Human Hepatitis B Immunoglobulin, Placenta Polypeptide, and Artificial Dura Mater among others. It offers products to hospitals, other healthcare facilities in China and to distributors. China Biologic is headquartered in Beijing, China.
China Biologic Products Holdings Inc premium industry data and analytics
Products and Services
Products |
---|
Human Fibrinogen |
Biopharmaceutical |
Human Albumin |
XYZ |
XYZ |
XYZ |
Competitor Comparison
Key Parameters | China Biologic Products Holdings Inc | Shanghai RAAS Blood Products Co Ltd | China Resources Boya Bio-pharmaceutical Group Co Ltd | China National Biotec Group | Sichuan Yuanda Shuyang Pharmaceutical Co Ltd |
---|---|---|---|---|---|
Headquarters | China | China | China | China | China |
City | Beijing | Shanghai | Fuzhou | Beijing | Chengdu |
State/Province | Beijing | Shanghai | Jiangxi | Beijing | Sichuan |
No. of Employees | 2,269 | 3,121 | 1,444 | 1,000 | - |
Entity Type | Private | Public | Public | Private | Private |
Executives
Name | Position | Board | Since | Age |
---|---|---|---|---|
Joseph Chow | Chairman; Chief Executive Officer | Executive Board | 2019 | - |
Gary Wang | Chief Financial Officer; Head - Plasma Collection Management | Senior Management | - | - |
Sun Bing | General Manager - Taibang TianXinFu | Senior Management | - | - |
Yuan Feng | Senior Vice President - Commercial Operation General Manager | Senior Management | - | - |
Guangli Pang | Executive Vice President - Plasma-derived Products Unit | Senior Management | - | - |
Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward